NCT00368576 - A Study To Determine The Effect Of SB-480848 On Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Atherosclerosis

Interventions

DRUG

SB 480848, tablets

Trial Locations (7)

GSK Investigational Site, Berlin

GSK Investigational Site, Großhansdorf

GSK Investigational Site, Spartanburg

GSK Investigational Site, Normal

GSK Investigational Site, Neu-Ulm

GSK Investigational Site, Cypress

GSK Investigational Site, North Dartmouth